Jeopardy!'s AI king. That's right, Watson, IBM's bold-face named powerhouse of silicon wizardry, will be made available as a development tool for oncologists at Memorial Sloan-Kettering to deliver "individualized cancer diagnostic and treatment recommendations" derived from the center's case note database. Drawing upon that raw processing power, field practitioners will purportedly have access to a wealth of the latest therapeutic advances which would, normally, take too long to spread outside of specialized facilities. The agreement is not the first of its kind, as this time last year IBM had announced a similar partnership with Columbia University, although no further news has come from that union. MSKCC, for its part, does have concrete plans to move its small pilot program forward, with a target launch set for later this year and plans to expand the project's reach by end of 2013. Jump past the break for the official presser.